Cargando…

CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex

The gene encoding the transcription factor C/EBPα is mutated in 10-15% of acute myeloid leukemia (AML) patients. N-terminal CEBPA mutations cause ablation of full-length C/EBPα without affecting the expression of a shorter oncogenic isoform, termed p30. The mechanistic basis of p30-induced leukemoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Luisa, Heyes, Elizabeth, Scheiblecker, Lisa, Eder, Thomas, Volpe, Giacomo, Frampton, Jon, Nerlov, Claus, Valent, Peter, Grembecka, Jolanta, Grebien, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612510/ https://www.ncbi.nlm.nih.gov/pubmed/30679799 http://dx.doi.org/10.1038/s41375-019-0382-3

Ejemplares similares

Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia
por: Schmidt, Luisa, et al.
Publicado: (2020)

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations
por: Volpe, Giacomo, et al.
Publicado: (2019)

TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
por: Heyes, Elizabeth, et al.
Publicado: (2023)

Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
por: Grebien, Florian, et al.
Publicado: (2015)

MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
por: Skucha, Anna, et al.
Publicado: (2018)

The PAF Complex Regulation of Prmt5 Facilitates the Progression and Maintenance of MLL-Fusion Leukemia
por: Serio, Justin, et al.
Publicado: (2017)

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
por: Feng, Zizhen, et al.
Publicado: (2016)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
por: Yuan, Ji, et al.
Publicado: (2023)

Pharmacologic inhibition of STAT5 in acute myeloid leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2018)

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
por: Pabst, T, et al.
Publicado: (2009)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

Expression level of CEBPA gene in acute lymphoblastic leukemia individuals
por: Szmajda, Dagmara, et al.
Publicado: (2019)

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
por: Hou, H-A, et al.
Publicado: (2009)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
por: Chan, Anthony K. N., et al.
Publicado: (2019)

Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia
por: Grossmann, V, et al.
Publicado: (2012)

Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
por: Xu, Xiaoyu, et al.
Publicado: (2021)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
por: Su, Long, et al.
Publicado: (2022)

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2022)

High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein Interaction
por: He, Shihan, et al.
Publicado: (2014)

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications
por: Molina Garay, Carolina, et al.
Publicado: (2022)

CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia
por: Hughes, James M, et al.
Publicado: (2014)

Two Novel CEBPA Mutations in a Turkish Patient with Acute Myeloid Leukemia
por: Tokgun, PE, et al.
Publicado: (2021)

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
por: Wakita, Satoshi, et al.
Publicado: (2022)

Acute myeloid leukemia due to germline CEBPA mutation in a Syrian family
por: Wafa, Abdulsamad, et al.
Publicado: (2022)

The MLL recombinome of acute leukemias in 2013
por: Meyer, C, et al.
Publicado: (2013)

The MLL recombinome of acute leukemias in 2017
por: Meyer, C, et al.
Publicado: (2018)

Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)
por: Sun, Q-Y, et al.
Publicado: (2017)

Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype
por: Kim, Sollip, et al.
Publicado: (2012)

In Silico Genetics Revealing 5 Mutations in CEBPA Gene Associated With Acute Myeloid Leukemia
por: Mustafa, Mujahed I, et al.
Publicado: (2019)

Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
por: Adamo, Assunta, et al.
Publicado: (2022)

Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin
por: Svoboda, Laurie K., et al.
Publicado: (2016)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009)

Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia
por: van der Linden, Marieke H., et al.
Publicado: (2015)

The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML
por: Rasouli, Milad, et al.
Publicado: (2023)

miR-150: targeting MLL leukemia
por: Jiang, Xi, et al.
Publicado: (2012)

RNA binding proteins in MLL-rearranged leukemia
por: Tran, Tiffany M., et al.
Publicado: (2022)

The ASXL1-G643Wvariant accelerates the development of CEBPA mutant acute myeloid leukemia
por: D’Altri, Teresa, et al.
Publicado: (2020)

RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy
por: Romanova, Ekaterina I., et al.
Publicado: (2022)

Location, location, location: A mini-review of CEBPA variants in patients with acute myeloid leukemia
por: Faisal, Muhammad Salman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ed48a67c1coo6ffrq3ujofvu7l